These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35753963)

  • 1. Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study.
    Salmasi S; Safari A; Kapanen A; Adelakun A; Kwan L; MacGillivray J; Andrade JG; Deyell MW; Loewen P
    Res Social Adm Pharm; 2022 Nov; 18(11):3920-3928. PubMed ID: 35753963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulant switching in patients with atrial fibrillation: a scoping review.
    Adelakun AR; Turgeon RD; De Vera MA; McGrail K; Loewen PS
    BMJ Open; 2023 Apr; 13(4):e071907. PubMed ID: 37185198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.
    Perreault S; de Denus S; White-Guay B; Côté R; Schnitzer ME; Dubé MP; Dorais M; Tardif JC
    Pharmacotherapy; 2020 Jan; 40(1):40-54. PubMed ID: 31758592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Smartphone App to Improve Oral Anticoagulation Adherence in Patients With Atrial Fibrillation: Prospective Observational Study.
    Senoo K; Miki T; Ohkura T; Iwakoshi H; Nishimura T; Shiraishi H; Teramukai S; Matoba S
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e30807. PubMed ID: 34894626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.
    Obamiro KO; Chalmers L; Lee K; Bereznicki BJ; Bereznicki LRE
    Int J Clin Pract; 2018 Mar; 72(3):e13072. PubMed ID: 29457323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF).
    Kim H; Lee YS; Kim TH; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Shim J; Uhm JS; Park HW; Choi EK; Kim JB; Kim C; Kim J; Joung B
    Korean J Intern Med; 2020 Jan; 35(1):99-108. PubMed ID: 31014064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study.
    Halvorsen S; Smith JA; Söderdahl F; Thuresson M; Solli O; Ulvestad M; Jonasson C
    BMC Prim Care; 2022 Aug; 23(1):214. PubMed ID: 36008778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study.
    Salmasi S; Adelakun A; Safari A; Kwan L; MacGillivray J; Andrade JG; Deyell MW; Kapanen A; Loewen P
    CJC Open; 2021 Nov; 3(11):1347-1356. PubMed ID: 34901803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study.
    Salmasi S; Safari A; De Vera MA; Högg T; Lynd LD; Koehoorn M; Barry AR; Andrade JG; Deyell MW; Rush KL; Zhao Y; Loewen P
    J Thromb Thrombolysis; 2024 Mar; 57(3):437-444. PubMed ID: 38103148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.
    Rolls CA; Obamiro KO; Chalmers L; Bereznicki LRE
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28869793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation.
    Brown TM; Siu K; Walker D; Pladevall-Vila M; Sander S; Mordin M
    J Manag Care Pharm; 2012 Jun; 18(5):351-62. PubMed ID: 22663168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anti-coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study.
    Ording AG; Søgaard M; Nielsen PB; Lip GYH; Larsen TB; Grove EL; Skjøth F
    Br J Haematol; 2022 Apr; 197(2):223-231. PubMed ID: 35194786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study.
    Miyazaki M; Nakashima A; Nakamura Y; Sakamoto Y; Matsuo K; Goto M; Uchiyama M; Okamura K; Mitsutake R; Urata H; Kamimura H; Imakyure O
    PLoS One; 2018; 13(9):e0204814. PubMed ID: 30265710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Hospitalization and Medication Switching on Post-discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation.
    Pham Nguyen TP; Chen Y; Thibault D; Leonard CE; Hennessy S; Willis A
    Pharmacotherapy; 2020 Oct; 40(10):1022-1035. PubMed ID: 32869324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
    Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
    BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry.
    Liu C; Du X; Jiang C; He L; Chang SS; Guo XY; Yu RH; Long DY; Bai R; Liu N; Sang CH; Jiang CX; Dong JZ; Lip GYH; Ma CS
    Med Sci Monit; 2019 Apr; 25():2649-2657. PubMed ID: 30971681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
    Manzoor BS; Lee TA; Sharp LK; Walton SM; Galanter WL; Nutescu EA
    Pharmacotherapy; 2017 Oct; 37(10):1221-1230. PubMed ID: 28730619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.